InvestorsHub Logo
Followers 11
Posts 534
Boards Moderated 0
Alias Born 02/23/2016

Re: longfellow95 post# 173861

Thursday, 05/24/2018 11:29:53 AM

Thursday, May 24, 2018 11:29:53 AM

Post# of 721281
It is early for RTT to have impact for a small pharma. Structure for RTT needs to be built and streamlined.

Longer term, I see this as a tool for BP. They can view which small pharma have buzz, client base, and patient anecdotal success and build that into their purchase algorithms. BP have clinical drugs and better resources to market RTT to their advantage, and apparently sell w/o phase III double blinded data.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News